Radnor, PA – March 9, 2017 – VWR (NASDAQ: VWR), the leading global independent provider of products and service solutions to laboratory and production customers, is excited to announce an agreement with Avantor® Performance Materials, LLC. This agreement will allow VWR to distribute Avantor’s beaker-to-bulk portfolio of J.T.Baker® and Macron Fine Chemicals™ brand laboratory and pharmaceutical products to all European countries except Poland. European customers in the biopharmaceutical, production, quality labs, research and education industries will all benefit from this offering.
“The J.T.Baker® and Macron Fine Chemicals™ brand portfolio is backed by Avantor’s robust global quality systems, cGMP manufacturing footprint and distinctive innovation model designed to provide customized solutions to address complex challenges at any scale. This agreement provides our customers access to a broader choice of quality products,” stated Dr. Nils Clausnitzer, SVP and President, EMEA-APAC Lab and Distribution Services for VWR. “VWR and Avantor’s longstanding history of collaboration will help us continue to drive positive results for our customers.”
“Avantor’s broad product portfolio and VWR’s extensive distribution capabilities and infrastructure allows both companies to better serve the growing needs of customers across Europe,” said Bjorn Hofman, Executive Vice President, Biopharma, Research & Diagnostics, for Avantor. “We are excited to work with VWR to provide a broader customer base access to our extensive offerings through VWR’s comprehensive distribution network.”
Avantor is a global supplier of ultra-high-purity materials for the life sciences and advanced technology industries. The company provides performance materials and solutions for the production and research needs of approximately 7,900 customers across the biotechnology, pharmaceutical, medical device, diagnostics, aerospace & defense, and semiconductor industries. The agreement makes VWR the exclusive distributor for J.T.Baker® and Macron Fine Chemicals™ brand pharmaceutical production chemistries in the majority of European countries. Avantor’s product portfolio includes more than 30,000 products that meet increasingly stringent standards across technology driven and highly regulated industries.
To learn more or to purchase Avantor products, please visit vwr.com or contact your local VWR Sales Representative.
About VWR
VWR (NASDAQ: VWR), headquartered in Radnor, Pennsylvania, is the leading global independent provider of product and service solutions to laboratory and production customers. With sales in excess of $4.5 billion in 2016, VWR enables science for customers in the pharmaceutical, biotechnology, industrial, education, government and healthcare industries. With more than 160 years of experience, VWR has cultivated a value proposition delivering product choice, operational excellence and differentiated services to improve our customers’ productivity from research to production. VWR’s differentiated services provide innovative, flexible and customized solutions from scientific research services to custom-manufactured chemical blends. Our dedicated team of more than 10,200 associates is focused on supporting scientists, medical professionals and production engineers to achieve their goals.
For more information on VWR, please visit www.vwr.com.
# # #
Media Contact:
Valerie Collado
Director, Corporate Communications
VWR
484.885.9338
Valerie_collado@vwr.com
Investor Contact:
John Sweeney, CFA
VP, Investor Relations
VWR Corporation
Phone: +610.386.1483
ir@vwr.com